Manufacturing

Articles

Through a collaboration, Avantor and Cytovance Biologics will accelerate plasmid optimization and sourcing services for viral vectors and mRNA-based vaccines and therapeutics.

Avantor and Cytovance Biologics Partner on Plasmid DNA Development

Arranta Bio will use Cytiva’s FlexFactory single-use manufacturing platform to produce mRNA vaccines.

Cytiva Provides Arranta Bio with Single-Use Manufacturing Platform for mRNA Products

Recipharm will build up its biologics service offering with the acquisition of GenIbet.

Recipharm Acquires Portuguese CDMO, GenIbet, Boosting Biologics Offering

Samsung Biologics, GreenLight Biosciences, and Environmental Impact Acquisition Corp. have partnered to advance GreenLight’s mRNA COVID-19 vaccine candidate.

Samsung Biologics, GreenLight Biosciences, and Environmental Impact Acquisition Corp to Build mRNA Vaccine Manufacturing Capacity

ANGUS’ planned expansion will double its tromethamine buffer production capacity.

ANGUS to Expand U.S. Manufacturing Capacity for Tromethamine Buffers

Feliza Mirasol is the science editor for 

The complexity of newer biotherapeutic molecules calls for alternative drug delivery strategies.

Next-Gen Technologies Tackle Drug Delivery Challenges

A new method developed by the NIH bypasses genetic RNA extraction, simplifying the testing process.

NIH Scientists Develop Faster COVID-19 Test

A collaboration between Aldevron and Ginkgo Bioworks has resulted in a manufacturing enhancement that can improve production of an enzyme used for mRNA therapeutics.

Aldevron and Ginkgo Bioworks Collaboration Yields mRNA Manufacturing Enhancement

AGC Biologics has partnered with BioNTech to further supply plasmid DNA starting material from its Heidelberg, Germany, facility for the Pfizer-BioNTech COVID-19 vaccine.

AGC Biologics to Supply More Plasmid DNA for Pfizer-BioNTech COVID-19 Vaccine

GSK and CureVac will collaborate on mRNA-based vaccines and mAbs. Separately, the EIB and others provided CureVac with financing for development of its CVnCoV vaccine candidate and expansion of manufacturing.

Manufacturing, Nucleic Acids